Cite
HARVARD Citation
Hofman, M. et al. (2018). [177Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer – Author's reply. Lancet oncology. 19 (8), pp. e373-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hofman, M. et al. (2018). [177Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer – Author's reply. Lancet oncology. 19 (8), pp. e373-. [Online].